Pharma & Healthcare
Global Generic Nifedipine Controlled-release Tablets Market Research Report 2026
- Mar 17, 26
- ID: 736740
- Pages: 113
- Figures: 116
- Views: 8
This report delivers a comprehensive overview of the global Generic Nifedipine Controlled-release Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Generic Nifedipine Controlled-release Tablets. The Generic Nifedipine Controlled-release Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Generic Nifedipine Controlled-release Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Generic Nifedipine Controlled-release Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Shanghai Shyndec Pharma
Simcere
Qingdao Baiyang Pharmaceutical
CR DOUBLE-CRANE
Hefei Cube Pharma
Deyao Pharma
Apichope
Nanjing Easeheal Pharma
Beijing Honglin Pharma
Segment by Type
30mg per Tablet
60mg per Tablet
by Application
Hypertension
Exertional Angina
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Generic Nifedipine Controlled-release Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Generic Nifedipine Controlled-release Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Generic Nifedipine Controlled-release Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Generic Nifedipine Controlled-release Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Shanghai Shyndec Pharma
Simcere
Qingdao Baiyang Pharmaceutical
CR DOUBLE-CRANE
Hefei Cube Pharma
Deyao Pharma
Apichope
Nanjing Easeheal Pharma
Beijing Honglin Pharma
Segment by Type
30mg per Tablet
60mg per Tablet
by Application
Hypertension
Exertional Angina
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Generic Nifedipine Controlled-release Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Generic Nifedipine Controlled-release Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Generic Nifedipine Controlled-release Tablets Market Overview
1.1 Product Definition
1.2 Generic Nifedipine Controlled-release Tablets by Type
1.2.1 Global Generic Nifedipine Controlled-release Tablets Market Value by Type: 2025 vs 2032
1.2.2 30mg per Tablet
1.2.3 60mg per Tablet
1.3 Generic Nifedipine Controlled-release Tablets by Application
1.3.1 Global Generic Nifedipine Controlled-release Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hypertension
1.3.3 Exertional Angina
1.3.4 Other
1.4 Global Generic Nifedipine Controlled-release Tablets Market Size Estimates and Forecasts
1.4.1 Global Generic Nifedipine Controlled-release Tablets Revenue 2021–2032
1.4.2 Global Generic Nifedipine Controlled-release Tablets Sales 2021–2032
1.4.3 Global Generic Nifedipine Controlled-release Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Generic Nifedipine Controlled-release Tablets Market Competition by Manufacturers
2.1 Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Generic Nifedipine Controlled-release Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Generic Nifedipine Controlled-release Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Generic Nifedipine Controlled-release Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Generic Nifedipine Controlled-release Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Generic Nifedipine Controlled-release Tablets, Date of Entry into the Industry
2.8 Global Generic Nifedipine Controlled-release Tablets Market Competitive Situation and Trends
2.8.1 Global Generic Nifedipine Controlled-release Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Generic Nifedipine Controlled-release Tablets Players Market Share by Revenue
2.8.3 Global Generic Nifedipine Controlled-release Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Generic Nifedipine Controlled-release Tablets Market Scenario by Region
3.1 Global Generic Nifedipine Controlled-release Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2021–2032
3.2.1 Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2021–2026
3.2.2 Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2027–2032
3.3 Global Generic Nifedipine Controlled-release Tablets Revenue by Region: 2021–2032
3.3.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Region: 2021–2026
3.3.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Region: 2027–2032
3.4 North America Generic Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.4.1 North America Generic Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Generic Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.4.3 North America Generic Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Generic Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.5.1 Europe Generic Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Generic Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.5.3 Europe Generic Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Generic Nifedipine Controlled-release Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Generic Nifedipine Controlled-release Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Generic Nifedipine Controlled-release Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Generic Nifedipine Controlled-release Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Generic Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.7.1 Latin America Generic Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Generic Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.7.3 Latin America Generic Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Generic Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Generic Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Generic Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Generic Nifedipine Controlled-release Tablets Sales by Type (2021–2032)
4.1.1 Global Generic Nifedipine Controlled-release Tablets Sales by Type (2021–2026)
4.1.2 Global Generic Nifedipine Controlled-release Tablets Sales by Type (2027–2032)
4.1.3 Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type (2021–2032)
4.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2021–2032)
4.2.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2021–2026)
4.2.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2027–2032)
4.2.3 Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Generic Nifedipine Controlled-release Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Generic Nifedipine Controlled-release Tablets Sales by Application (2021–2032)
5.1.1 Global Generic Nifedipine Controlled-release Tablets Sales by Application (2021–2026)
5.1.2 Global Generic Nifedipine Controlled-release Tablets Sales by Application (2027–2032)
5.1.3 Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application (2021–2032)
5.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2021–2032)
5.2.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2021–2026)
5.2.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2027–2032)
5.2.3 Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Generic Nifedipine Controlled-release Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Shanghai Shyndec Pharma
6.1.1 Shanghai Shyndec Pharma Company Information
6.1.2 Shanghai Shyndec Pharma Description and Business Overview
6.1.3 Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
6.1.5 Shanghai Shyndec Pharma Recent Developments/Updates
6.2 Simcere
6.2.1 Simcere Company Information
6.2.2 Simcere Description and Business Overview
6.2.3 Simcere Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Simcere Generic Nifedipine Controlled-release Tablets Product Portfolio
6.2.5 Simcere Recent Developments/Updates
6.3 Qingdao Baiyang Pharmaceutical
6.3.1 Qingdao Baiyang Pharmaceutical Company Information
6.3.2 Qingdao Baiyang Pharmaceutical Description and Business Overview
6.3.3 Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Product Portfolio
6.3.5 Qingdao Baiyang Pharmaceutical Recent Developments/Updates
6.4 CR DOUBLE-CRANE
6.4.1 CR DOUBLE-CRANE Company Information
6.4.2 CR DOUBLE-CRANE Description and Business Overview
6.4.3 CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Product Portfolio
6.4.5 CR DOUBLE-CRANE Recent Developments/Updates
6.5 Hefei Cube Pharma
6.5.1 Hefei Cube Pharma Company Information
6.5.2 Hefei Cube Pharma Description and Business Overview
6.5.3 Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
6.5.5 Hefei Cube Pharma Recent Developments/Updates
6.6 Deyao Pharma
6.6.1 Deyao Pharma Company Information
6.6.2 Deyao Pharma Description and Business Overview
6.6.3 Deyao Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Deyao Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
6.6.5 Deyao Pharma Recent Developments/Updates
6.7 Apichope
6.7.1 Apichope Company Information
6.7.2 Apichope Description and Business Overview
6.7.3 Apichope Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Apichope Generic Nifedipine Controlled-release Tablets Product Portfolio
6.7.5 Apichope Recent Developments/Updates
6.8 Nanjing Easeheal Pharma
6.8.1 Nanjing Easeheal Pharma Company Information
6.8.2 Nanjing Easeheal Pharma Description and Business Overview
6.8.3 Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
6.8.5 Nanjing Easeheal Pharma Recent Developments/Updates
6.9 Beijing Honglin Pharma
6.9.1 Beijing Honglin Pharma Company Information
6.9.2 Beijing Honglin Pharma Description and Business Overview
6.9.3 Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
6.9.5 Beijing Honglin Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Generic Nifedipine Controlled-release Tablets Industry Chain Analysis
7.2 Generic Nifedipine Controlled-release Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Generic Nifedipine Controlled-release Tablets Production Mode & Process Analysis
7.4 Generic Nifedipine Controlled-release Tablets Sales and Marketing
7.4.1 Generic Nifedipine Controlled-release Tablets Sales Channels
7.4.2 Generic Nifedipine Controlled-release Tablets Distributors
7.5 Generic Nifedipine Controlled-release Tablets Customer Analysis
8 Generic Nifedipine Controlled-release Tablets Market Dynamics
8.1 Generic Nifedipine Controlled-release Tablets Industry Trends
8.2 Generic Nifedipine Controlled-release Tablets Market Drivers
8.3 Generic Nifedipine Controlled-release Tablets Market Challenges
8.4 Generic Nifedipine Controlled-release Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Generic Nifedipine Controlled-release Tablets by Type
1.2.1 Global Generic Nifedipine Controlled-release Tablets Market Value by Type: 2025 vs 2032
1.2.2 30mg per Tablet
1.2.3 60mg per Tablet
1.3 Generic Nifedipine Controlled-release Tablets by Application
1.3.1 Global Generic Nifedipine Controlled-release Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hypertension
1.3.3 Exertional Angina
1.3.4 Other
1.4 Global Generic Nifedipine Controlled-release Tablets Market Size Estimates and Forecasts
1.4.1 Global Generic Nifedipine Controlled-release Tablets Revenue 2021–2032
1.4.2 Global Generic Nifedipine Controlled-release Tablets Sales 2021–2032
1.4.3 Global Generic Nifedipine Controlled-release Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Generic Nifedipine Controlled-release Tablets Market Competition by Manufacturers
2.1 Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Generic Nifedipine Controlled-release Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Generic Nifedipine Controlled-release Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Generic Nifedipine Controlled-release Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Generic Nifedipine Controlled-release Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Generic Nifedipine Controlled-release Tablets, Date of Entry into the Industry
2.8 Global Generic Nifedipine Controlled-release Tablets Market Competitive Situation and Trends
2.8.1 Global Generic Nifedipine Controlled-release Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Generic Nifedipine Controlled-release Tablets Players Market Share by Revenue
2.8.3 Global Generic Nifedipine Controlled-release Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Generic Nifedipine Controlled-release Tablets Market Scenario by Region
3.1 Global Generic Nifedipine Controlled-release Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2021–2032
3.2.1 Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2021–2026
3.2.2 Global Generic Nifedipine Controlled-release Tablets Sales by Region: 2027–2032
3.3 Global Generic Nifedipine Controlled-release Tablets Revenue by Region: 2021–2032
3.3.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Region: 2021–2026
3.3.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Region: 2027–2032
3.4 North America Generic Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.4.1 North America Generic Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Generic Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.4.3 North America Generic Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Generic Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.5.1 Europe Generic Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Generic Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.5.3 Europe Generic Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Generic Nifedipine Controlled-release Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Generic Nifedipine Controlled-release Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Generic Nifedipine Controlled-release Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Generic Nifedipine Controlled-release Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Generic Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.7.1 Latin America Generic Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Generic Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.7.3 Latin America Generic Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Generic Nifedipine Controlled-release Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Generic Nifedipine Controlled-release Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Generic Nifedipine Controlled-release Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Generic Nifedipine Controlled-release Tablets Sales by Type (2021–2032)
4.1.1 Global Generic Nifedipine Controlled-release Tablets Sales by Type (2021–2026)
4.1.2 Global Generic Nifedipine Controlled-release Tablets Sales by Type (2027–2032)
4.1.3 Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type (2021–2032)
4.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2021–2032)
4.2.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2021–2026)
4.2.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Type (2027–2032)
4.2.3 Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Generic Nifedipine Controlled-release Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Generic Nifedipine Controlled-release Tablets Sales by Application (2021–2032)
5.1.1 Global Generic Nifedipine Controlled-release Tablets Sales by Application (2021–2026)
5.1.2 Global Generic Nifedipine Controlled-release Tablets Sales by Application (2027–2032)
5.1.3 Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application (2021–2032)
5.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2021–2032)
5.2.1 Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2021–2026)
5.2.2 Global Generic Nifedipine Controlled-release Tablets Revenue by Application (2027–2032)
5.2.3 Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Generic Nifedipine Controlled-release Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Shanghai Shyndec Pharma
6.1.1 Shanghai Shyndec Pharma Company Information
6.1.2 Shanghai Shyndec Pharma Description and Business Overview
6.1.3 Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
6.1.5 Shanghai Shyndec Pharma Recent Developments/Updates
6.2 Simcere
6.2.1 Simcere Company Information
6.2.2 Simcere Description and Business Overview
6.2.3 Simcere Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Simcere Generic Nifedipine Controlled-release Tablets Product Portfolio
6.2.5 Simcere Recent Developments/Updates
6.3 Qingdao Baiyang Pharmaceutical
6.3.1 Qingdao Baiyang Pharmaceutical Company Information
6.3.2 Qingdao Baiyang Pharmaceutical Description and Business Overview
6.3.3 Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Product Portfolio
6.3.5 Qingdao Baiyang Pharmaceutical Recent Developments/Updates
6.4 CR DOUBLE-CRANE
6.4.1 CR DOUBLE-CRANE Company Information
6.4.2 CR DOUBLE-CRANE Description and Business Overview
6.4.3 CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Product Portfolio
6.4.5 CR DOUBLE-CRANE Recent Developments/Updates
6.5 Hefei Cube Pharma
6.5.1 Hefei Cube Pharma Company Information
6.5.2 Hefei Cube Pharma Description and Business Overview
6.5.3 Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
6.5.5 Hefei Cube Pharma Recent Developments/Updates
6.6 Deyao Pharma
6.6.1 Deyao Pharma Company Information
6.6.2 Deyao Pharma Description and Business Overview
6.6.3 Deyao Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Deyao Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
6.6.5 Deyao Pharma Recent Developments/Updates
6.7 Apichope
6.7.1 Apichope Company Information
6.7.2 Apichope Description and Business Overview
6.7.3 Apichope Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Apichope Generic Nifedipine Controlled-release Tablets Product Portfolio
6.7.5 Apichope Recent Developments/Updates
6.8 Nanjing Easeheal Pharma
6.8.1 Nanjing Easeheal Pharma Company Information
6.8.2 Nanjing Easeheal Pharma Description and Business Overview
6.8.3 Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
6.8.5 Nanjing Easeheal Pharma Recent Developments/Updates
6.9 Beijing Honglin Pharma
6.9.1 Beijing Honglin Pharma Company Information
6.9.2 Beijing Honglin Pharma Description and Business Overview
6.9.3 Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Product Portfolio
6.9.5 Beijing Honglin Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Generic Nifedipine Controlled-release Tablets Industry Chain Analysis
7.2 Generic Nifedipine Controlled-release Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Generic Nifedipine Controlled-release Tablets Production Mode & Process Analysis
7.4 Generic Nifedipine Controlled-release Tablets Sales and Marketing
7.4.1 Generic Nifedipine Controlled-release Tablets Sales Channels
7.4.2 Generic Nifedipine Controlled-release Tablets Distributors
7.5 Generic Nifedipine Controlled-release Tablets Customer Analysis
8 Generic Nifedipine Controlled-release Tablets Market Dynamics
8.1 Generic Nifedipine Controlled-release Tablets Industry Trends
8.2 Generic Nifedipine Controlled-release Tablets Market Drivers
8.3 Generic Nifedipine Controlled-release Tablets Market Challenges
8.4 Generic Nifedipine Controlled-release Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Generic Nifedipine Controlled-release Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Generic Nifedipine Controlled-release Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Generic Nifedipine Controlled-release Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Generic Nifedipine Controlled-release Tablets Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Generic Nifedipine Controlled-release Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Generic Nifedipine Controlled-release Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Generic Nifedipine Controlled-release Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Generic Nifedipine Controlled-release Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Generic Nifedipine Controlled-release Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Generic Nifedipine Controlled-release Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Generic Nifedipine Controlled-release Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Generic Nifedipine Controlled-release Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Generic Nifedipine Controlled-release Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Generic Nifedipine Controlled-release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Generic Nifedipine Controlled-release Tablets Sales by Region (K Units), 2021–2026
Table 18. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Generic Nifedipine Controlled-release Tablets Sales by Region (K Units), 2027–2032
Table 20. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Generic Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Generic Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Generic Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2021–2026
Table 27. North America Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2027–2032
Table 28. North America Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Generic Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2021–2026
Table 32. Europe Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2027–2032
Table 33. Europe Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Generic Nifedipine Controlled-release Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Generic Nifedipine Controlled-release Tablets Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Generic Nifedipine Controlled-release Tablets Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Generic Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Generic Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Generic Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2021–2026
Table 42. Latin America Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2027–2032
Table 43. Latin America Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Generic Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Generic Nifedipine Controlled-release Tablets Sales (K Units) by Type (2021–2026)
Table 51. Global Generic Nifedipine Controlled-release Tablets Sales (K Units) by Type (2027–2032)
Table 52. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Generic Nifedipine Controlled-release Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Generic Nifedipine Controlled-release Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Generic Nifedipine Controlled-release Tablets Price (US$/Unit) by Type (2021–2026)
Table 59. Global Generic Nifedipine Controlled-release Tablets Price (US$/Unit) by Type (2027–2032)
Table 60. Global Generic Nifedipine Controlled-release Tablets Sales (K Units) by Application (2021–2026)
Table 61. Global Generic Nifedipine Controlled-release Tablets Sales (K Units) by Application (2027–2032)
Table 62. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Generic Nifedipine Controlled-release Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Generic Nifedipine Controlled-release Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Generic Nifedipine Controlled-release Tablets Price (US$/Unit) by Application (2021–2026)
Table 69. Global Generic Nifedipine Controlled-release Tablets Price (US$/Unit) by Application (2027–2032)
Table 70. Shanghai Shyndec Pharma Company Information
Table 71. Shanghai Shyndec Pharma Description and Business Overview
Table 72. Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Product
Table 74. Shanghai Shyndec Pharma Recent Developments/Updates
Table 75. Simcere Company Information
Table 76. Simcere Description and Business Overview
Table 77. Simcere Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Simcere Generic Nifedipine Controlled-release Tablets Product
Table 79. Simcere Recent Developments/Updates
Table 80. Qingdao Baiyang Pharmaceutical Company Information
Table 81. Qingdao Baiyang Pharmaceutical Description and Business Overview
Table 82. Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Product
Table 84. Qingdao Baiyang Pharmaceutical Recent Developments/Updates
Table 85. CR DOUBLE-CRANE Company Information
Table 86. CR DOUBLE-CRANE Description and Business Overview
Table 87. CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Product
Table 89. CR DOUBLE-CRANE Recent Developments/Updates
Table 90. Hefei Cube Pharma Company Information
Table 91. Hefei Cube Pharma Description and Business Overview
Table 92. Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Product
Table 94. Hefei Cube Pharma Recent Developments/Updates
Table 95. Deyao Pharma Company Information
Table 96. Deyao Pharma Description and Business Overview
Table 97. Deyao Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Deyao Pharma Generic Nifedipine Controlled-release Tablets Product
Table 99. Deyao Pharma Recent Developments/Updates
Table 100. Apichope Company Information
Table 101. Apichope Description and Business Overview
Table 102. Apichope Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Apichope Generic Nifedipine Controlled-release Tablets Product
Table 104. Apichope Recent Developments/Updates
Table 105. Nanjing Easeheal Pharma Company Information
Table 106. Nanjing Easeheal Pharma Description and Business Overview
Table 107. Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Product
Table 109. Nanjing Easeheal Pharma Recent Developments/Updates
Table 110. Beijing Honglin Pharma Company Information
Table 111. Beijing Honglin Pharma Description and Business Overview
Table 112. Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Product
Table 114. Beijing Honglin Pharma Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Generic Nifedipine Controlled-release Tablets Distributors List
Table 118. Generic Nifedipine Controlled-release Tablets Customers List
Table 119. Generic Nifedipine Controlled-release Tablets Market Trends
Table 120. Generic Nifedipine Controlled-release Tablets Market Drivers
Table 121. Generic Nifedipine Controlled-release Tablets Market Challenges
Table 122. Generic Nifedipine Controlled-release Tablets Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Generic Nifedipine Controlled-release Tablets
Figure 2. Global Generic Nifedipine Controlled-release Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Generic Nifedipine Controlled-release Tablets Market Share by Type: 2025 & 2032
Figure 4. 30mg per Tablet Product Picture
Figure 5. 60mg per Tablet Product Picture
Figure 6. Global Generic Nifedipine Controlled-release Tablets Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Generic Nifedipine Controlled-release Tablets Market Share by Application: 2025 & 2032
Figure 8. Hypertension
Figure 9. Exertional Angina
Figure 10. Other
Figure 11. Global Generic Nifedipine Controlled-release Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Generic Nifedipine Controlled-release Tablets Market Size (US$ Million), 2021–2032
Figure 13. Global Generic Nifedipine Controlled-release Tablets Sales (K Units), 2021–2032
Figure 14. Global Generic Nifedipine Controlled-release Tablets Average Price (US$/Unit), 2021–2032
Figure 15. Generic Nifedipine Controlled-release Tablets Report Years Considered
Figure 16. Generic Nifedipine Controlled-release Tablets Sales Share by Manufacturers in 2025
Figure 17. Global Generic Nifedipine Controlled-release Tablets Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Generic Nifedipine Controlled-release Tablets Players: Market Share by Revenue in Generic Nifedipine Controlled-release Tablets in 2025
Figure 19. Generic Nifedipine Controlled-release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Generic Nifedipine Controlled-release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Generic Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 22. North America Generic Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 23. United States Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Generic Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 26. Europe Generic Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 27. Germany Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Generic Nifedipine Controlled-release Tablets Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Generic Nifedipine Controlled-release Tablets Revenue Market Share by Region (2021–2032)
Figure 34. China Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Generic Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 42. Latin America Generic Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Generic Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Generic Nifedipine Controlled-release Tablets by Type (2021–2032)
Figure 53. Global Revenue Market Share of Generic Nifedipine Controlled-release Tablets by Type (2021–2032)
Figure 54. Global Generic Nifedipine Controlled-release Tablets Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Generic Nifedipine Controlled-release Tablets by Application (2021–2032)
Figure 56. Global Revenue Market Share of Generic Nifedipine Controlled-release Tablets by Application (2021–2032)
Figure 57. Global Generic Nifedipine Controlled-release Tablets Price (US$/Unit) by Application (2021–2032)
Figure 58. Generic Nifedipine Controlled-release Tablets Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Generic Nifedipine Controlled-release Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Generic Nifedipine Controlled-release Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Generic Nifedipine Controlled-release Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Generic Nifedipine Controlled-release Tablets Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Generic Nifedipine Controlled-release Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Generic Nifedipine Controlled-release Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Generic Nifedipine Controlled-release Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Generic Nifedipine Controlled-release Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Generic Nifedipine Controlled-release Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Generic Nifedipine Controlled-release Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Generic Nifedipine Controlled-release Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Generic Nifedipine Controlled-release Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Generic Nifedipine Controlled-release Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Generic Nifedipine Controlled-release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Generic Nifedipine Controlled-release Tablets Sales by Region (K Units), 2021–2026
Table 18. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Generic Nifedipine Controlled-release Tablets Sales by Region (K Units), 2027–2032
Table 20. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Generic Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Generic Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Generic Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2021–2026
Table 27. North America Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2027–2032
Table 28. North America Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Generic Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2021–2026
Table 32. Europe Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2027–2032
Table 33. Europe Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Generic Nifedipine Controlled-release Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Generic Nifedipine Controlled-release Tablets Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Generic Nifedipine Controlled-release Tablets Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Generic Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Generic Nifedipine Controlled-release Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Generic Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2021–2026
Table 42. Latin America Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2027–2032
Table 43. Latin America Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Generic Nifedipine Controlled-release Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Generic Nifedipine Controlled-release Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Generic Nifedipine Controlled-release Tablets Sales (K Units) by Type (2021–2026)
Table 51. Global Generic Nifedipine Controlled-release Tablets Sales (K Units) by Type (2027–2032)
Table 52. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Generic Nifedipine Controlled-release Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Generic Nifedipine Controlled-release Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Generic Nifedipine Controlled-release Tablets Price (US$/Unit) by Type (2021–2026)
Table 59. Global Generic Nifedipine Controlled-release Tablets Price (US$/Unit) by Type (2027–2032)
Table 60. Global Generic Nifedipine Controlled-release Tablets Sales (K Units) by Application (2021–2026)
Table 61. Global Generic Nifedipine Controlled-release Tablets Sales (K Units) by Application (2027–2032)
Table 62. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Generic Nifedipine Controlled-release Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Generic Nifedipine Controlled-release Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Generic Nifedipine Controlled-release Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Generic Nifedipine Controlled-release Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Generic Nifedipine Controlled-release Tablets Price (US$/Unit) by Application (2021–2026)
Table 69. Global Generic Nifedipine Controlled-release Tablets Price (US$/Unit) by Application (2027–2032)
Table 70. Shanghai Shyndec Pharma Company Information
Table 71. Shanghai Shyndec Pharma Description and Business Overview
Table 72. Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Shanghai Shyndec Pharma Generic Nifedipine Controlled-release Tablets Product
Table 74. Shanghai Shyndec Pharma Recent Developments/Updates
Table 75. Simcere Company Information
Table 76. Simcere Description and Business Overview
Table 77. Simcere Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Simcere Generic Nifedipine Controlled-release Tablets Product
Table 79. Simcere Recent Developments/Updates
Table 80. Qingdao Baiyang Pharmaceutical Company Information
Table 81. Qingdao Baiyang Pharmaceutical Description and Business Overview
Table 82. Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Qingdao Baiyang Pharmaceutical Generic Nifedipine Controlled-release Tablets Product
Table 84. Qingdao Baiyang Pharmaceutical Recent Developments/Updates
Table 85. CR DOUBLE-CRANE Company Information
Table 86. CR DOUBLE-CRANE Description and Business Overview
Table 87. CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. CR DOUBLE-CRANE Generic Nifedipine Controlled-release Tablets Product
Table 89. CR DOUBLE-CRANE Recent Developments/Updates
Table 90. Hefei Cube Pharma Company Information
Table 91. Hefei Cube Pharma Description and Business Overview
Table 92. Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Hefei Cube Pharma Generic Nifedipine Controlled-release Tablets Product
Table 94. Hefei Cube Pharma Recent Developments/Updates
Table 95. Deyao Pharma Company Information
Table 96. Deyao Pharma Description and Business Overview
Table 97. Deyao Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Deyao Pharma Generic Nifedipine Controlled-release Tablets Product
Table 99. Deyao Pharma Recent Developments/Updates
Table 100. Apichope Company Information
Table 101. Apichope Description and Business Overview
Table 102. Apichope Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Apichope Generic Nifedipine Controlled-release Tablets Product
Table 104. Apichope Recent Developments/Updates
Table 105. Nanjing Easeheal Pharma Company Information
Table 106. Nanjing Easeheal Pharma Description and Business Overview
Table 107. Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Nanjing Easeheal Pharma Generic Nifedipine Controlled-release Tablets Product
Table 109. Nanjing Easeheal Pharma Recent Developments/Updates
Table 110. Beijing Honglin Pharma Company Information
Table 111. Beijing Honglin Pharma Description and Business Overview
Table 112. Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Beijing Honglin Pharma Generic Nifedipine Controlled-release Tablets Product
Table 114. Beijing Honglin Pharma Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Generic Nifedipine Controlled-release Tablets Distributors List
Table 118. Generic Nifedipine Controlled-release Tablets Customers List
Table 119. Generic Nifedipine Controlled-release Tablets Market Trends
Table 120. Generic Nifedipine Controlled-release Tablets Market Drivers
Table 121. Generic Nifedipine Controlled-release Tablets Market Challenges
Table 122. Generic Nifedipine Controlled-release Tablets Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Generic Nifedipine Controlled-release Tablets
Figure 2. Global Generic Nifedipine Controlled-release Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Generic Nifedipine Controlled-release Tablets Market Share by Type: 2025 & 2032
Figure 4. 30mg per Tablet Product Picture
Figure 5. 60mg per Tablet Product Picture
Figure 6. Global Generic Nifedipine Controlled-release Tablets Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Generic Nifedipine Controlled-release Tablets Market Share by Application: 2025 & 2032
Figure 8. Hypertension
Figure 9. Exertional Angina
Figure 10. Other
Figure 11. Global Generic Nifedipine Controlled-release Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Generic Nifedipine Controlled-release Tablets Market Size (US$ Million), 2021–2032
Figure 13. Global Generic Nifedipine Controlled-release Tablets Sales (K Units), 2021–2032
Figure 14. Global Generic Nifedipine Controlled-release Tablets Average Price (US$/Unit), 2021–2032
Figure 15. Generic Nifedipine Controlled-release Tablets Report Years Considered
Figure 16. Generic Nifedipine Controlled-release Tablets Sales Share by Manufacturers in 2025
Figure 17. Global Generic Nifedipine Controlled-release Tablets Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Generic Nifedipine Controlled-release Tablets Players: Market Share by Revenue in Generic Nifedipine Controlled-release Tablets in 2025
Figure 19. Generic Nifedipine Controlled-release Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Generic Nifedipine Controlled-release Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Generic Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 22. North America Generic Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 23. United States Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Generic Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 26. Europe Generic Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 27. Germany Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Generic Nifedipine Controlled-release Tablets Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Generic Nifedipine Controlled-release Tablets Revenue Market Share by Region (2021–2032)
Figure 34. China Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Generic Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 42. Latin America Generic Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Generic Nifedipine Controlled-release Tablets Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Generic Nifedipine Controlled-release Tablets Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Generic Nifedipine Controlled-release Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Generic Nifedipine Controlled-release Tablets by Type (2021–2032)
Figure 53. Global Revenue Market Share of Generic Nifedipine Controlled-release Tablets by Type (2021–2032)
Figure 54. Global Generic Nifedipine Controlled-release Tablets Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Generic Nifedipine Controlled-release Tablets by Application (2021–2032)
Figure 56. Global Revenue Market Share of Generic Nifedipine Controlled-release Tablets by Application (2021–2032)
Figure 57. Global Generic Nifedipine Controlled-release Tablets Price (US$/Unit) by Application (2021–2032)
Figure 58. Generic Nifedipine Controlled-release Tablets Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232